Phytodolor® - Effects and efficacy of a Herbal Medicine

Wiener Medizinische Wochenschrift

Volumn 157, Issue 13-14, 2007, Pages 343-347

  Gundermann, Karl Josef ^a,c   Müller, Jürgen ^b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Steigerwald Arzneimittelwerk GmbH   (Germany)

^c NONE   (Germany)

Author keywords

Antirheumatics; Phytodolor ; Phytomedicine; Review; Rheumatic pain

Indexed keywords

DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; PHYTODOLOR; PLACEBO; PLANT EXTRACT; ROFECOXIB; UNCLASSIFIED DRUG; ANTIRHEUMATIC AGENT; PHYTODOLOR N;

ASPEN; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; FRAXINUS; HUMAN; NONHUMAN; PHYTOTHERAPY; REVIEW; RHEUMATIC DISEASE; SOLIDAGO; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; DOUBLE BLIND PROCEDURE; RANDOMIZED CONTROLLED TRIAL; RAT; SAFETY;

ANIMALS; ANTIRHEUMATIC AGENTS; DISEASE MODELS, ANIMAL; DOUBLE-BLIND METHOD; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS; RATS; RHEUMATIC DISEASES; SAFETY;

EID: 34548382231     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-007-0436-4     Document Type: Review

References (25)

1. Setty AR, Sigal H (2005) Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin Arthritis Rheum 34: 773-784
2. Rao J, Mihaliak K, Kroenke K, Bradley J, Tierney W, Weinberger M (1999) Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 131: 409-416
3. PDR (Physician's Desk Reference) for Herbal Medicines, 2nd ed.; edt. by Medical Economics Company, Montvale, New Jersey, USA, 2000, pages 51, 290 and 608
4. Rohnert U, Schneider W, Elstner EF (1998) Superoxide-dependent and -independent nitrite formation from hydroxylamine: inhibition by plant extracts. Z Naturforsch 53: 241-249
5. Rohnert U, Koske D, Schneider W, Elstner EF (1998) Inhibition by Salix-extracts and Phytodolor® of copper-catalyzed oxidative destructions. Z Naturforsch 53c:233-240
6. Kruedener S v, Schneider W, Elstner EF (1996) Effects of extracts from Populus tremula L., Solidago virgaurea L. and Fraxinus excelsior L. on various myeloperoxidase systems. Drug Res 46(II): 809-814
7. Hartwich I, Germann I, Kelber O, Müller J, Weiser D, Heinle H (2006) The antirheumatic phytomedicine STW 1 has antioxidative effects. Z Rheumatol 65(Suppl 1): 28
8. Meyer B, Schneider W, Elstner EF (1995) Antioxidative properties of alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea. Drug Res 45(I):174-176
9. Schempp H, Weiser D, Elstner EF (2000) Biochemical model reactions indicative of inflammatory processes-Activities of extracts from Fraxinus excelsior and Populus tremula. Drug Res 50(I): 362-372
10. Schaser J, Bonaterra GA, Kelber O, Weiser D, Kinscherf R, Metz J (2006) Untersuchungen antiinflammatorischer Effekte des Phytopharmakons Phytodolor und seiner Einzelkomponenten in einem Monozyten-Testmodell. Perfusion 19: 76-77
11. Strehl E, Schneider W, Elstner EF (1995) Inhibition of dihydrofolate reductase activity by alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea. Drug Res 45(I): 172-173
12. Hahn S, Hübner-Steiner U (1988) Treatment of painful rheumatic diseases with Phytodolor in comparison to placebo and Amuno treatment. Rheuma, Schmerz & Entzündung 8: 55-58
13. Schreckenberger F (1988) The treatment of epicondylitis with Phytodolor. Der praktische Arzt 42: 1638-1644
14. Huber B (1991) Therapy of degenerative rheumatic diseases - Requirement for additional analgesic medication under treatment with Phytodolor N. Fortschr Med 109: 248-50
15. Schadler W (1988) Phytodolor for the treatment of activated arthrosis. Rheuma 8: 288-290
16. Dunky A, Eberl R (1986) Treatment of rheumatic diseases with a plant-based antirheumatic. Therapiewoche 36: 3226-3228
17. Klose H-H (1988) A phytotherapeutic agent for post-operative pain treatment. Therapiewoche 38: 3584-3585
18. Speders S (1988) Phytodolor for the treatment of degenerative spinal diseases. Forum Dr.med. 7-8: 29-30
19. Reiter W, Frerick H, Schmidt U, Schenk N (1989) What does an antirheumatic agent composed of plant ingredients achieve in the therapy of chronic polyarthritis? Therapiewoche 39: 3409-3414
20. Holzgartner H, Schmidt U, Frerick H, Schenk N (1989) Experience with Phytodolor for the treatment of predominantly subacute rheumatic symptoms in a private internal medicine practice. Rheuma, Schmerz & Entzündung 9: 52-54
21. Michael J (1990) Treatment of rheumatic and degenerative joint diseases with Phytodolor N in orthopaedics. Rheuma-Schmerz & Entzündung 10: 34-38
22. Rauch G, Rauch S (1991) Rheumatic pain - Ash, American aspen (trembling poplar) and golden rod chase it away. Ärztl Praxis 5: 22-23
23. Gundermann K-J, Godehardt E, Ulbrich M (2007) Summarizing evaluation of randomized double-blind trials with Phytodolor N. Publication under Preparation
24. Ernst E (1999) The efficacy of Phytodolor® for the treatment of musculoskeletal pain - a systematic review of randomized clinical trials. Nat Med 2: 14-17
25. Ernst E, Chrubasik S (2000) Phyto-anti-inflammatories - a systematic review of randomized, placebo-controlled, double-blind trials. Complement Altern Ther Rheum Dis II 26: 13-27